The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II basket study to evaluate the tissue-agnostic efficacy of anti-PD1 in patients with advanced rare tumors: The ANTARES trial.
 
Camila Venchiarutti Moniz
Honoraria - Libbs
Research Funding - BMS; Immix BioPharma; Jazz Pharmaceuticals; Merck; Servier/Pfizer; Takeda
Travel, Accommodations, Expenses - Libbs; Merck
 
Renata Bonadio
Consulting or Advisory Role - Ache Company; MSD
Speakers' Bureau - Adium Pharma; AstraZeneca; BMS Brazil; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; MSD; Nestle health science; Pfizer
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; MSD; MSD
 
Raelson Miranda
No Relationships to Disclose
 
Jose Mauricio Mota
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen; Merck; Novartis; Pfizer; Zodiac Pharma
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen Oncology; Merck; Novartis; Pfizer; Zodiac Pharma
Research Funding - Bayer
Expert Testimony - Adium Pharma; Astellas Pharma; Bayer
Travel, Accommodations, Expenses - Janssen Oncology; Zodiac Pharma
 
Olavo Feher
No Relationships to Disclose
 
Gilberto De Castro, Jr.
No Relationships to Disclose
 
Milena Mak
Honoraria - Bristol-Myers Squibb; Johnson & Johnson/Janssen; Lilly; Merck KGaA; Sanofi; United Medical
Travel, Accommodations, Expenses - Knight Pharmaceuticals
 
Jorge Sabbaga
Speakers' Bureau - Abbott Laboratories
 
Laura Testa
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; MSD Oncology; MSD/AstraZeneca; Novartis; Pfizer
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; MSD Oncology; Roche
 
Mariana Petaccia de Macedo
No Relationships to Disclose
 
Vanessa Miranda
No Relationships to Disclose
 
Marcelo Queiroz
No Relationships to Disclose
 
Roger Chammas
No Relationships to Disclose
 
Maria Estevez-Diz
Consulting or Advisory Role - AstraZeneca/MedImmune
 
Paulo Hoff
Leadership - Oncologia D’Or
Stock and Other Ownership Interests - Oncostar
Honoraria - Bayer Health (I); United medical (I)
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (I); EMS; EMS; Exelixis (I); Lilly (I); United Health Group (I)
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); BMS Brazil (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Exelixis (Inst); Lilly (I); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca